ClinicalTrials.Veeva

Menu

Evaluation of Inhaled Treatment in Sinusitis

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status and phase

Completed
Phase 3
Phase 2

Conditions

Sinusitis

Treatments

Drug: methylprednisolone
Drug: Budesonide

Study type

Interventional

Funder types

Other

Identifiers

NCT01907204
Sinusitis001

Details and patient eligibility

About

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Enrollment

50 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Nasal/Sinus polyps

Exclusion criteria

  • Previous sinus surgery
  • Age under 18y
  • Use of antibiotics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 3 patient groups

Oral
Active Comparator group
Description:
Oral drug (methylprednisolone) administration
Treatment:
Drug: methylprednisolone
Metered dose inhaler
Experimental group
Treatment:
Drug: Budesonide
Drug: Budesonide
Nebulized
Experimental group
Treatment:
Drug: Budesonide
Drug: Budesonide

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems